|
"wu cw"的相關文件
顯示項目 136-145 / 215 (共22頁)
<< < 9 10 11 12 13 14 15 16 17 18 > >>
每頁顯示[10|25|50]項目
| 國立臺灣大學 |
2003-12 |
Up-regulation of vascular endothelial growth factor C in breast cancer cells by heregulin-beta1. A critical role of p38/NF-kB signaling pathway.
|
Tsai, PW; Shiah, SG; Lin, MT; Wu, CW; Kuo, ML |
| 國家衛生研究院 |
2003-11 |
Inhibition of invasion and angiogenesis by zinc-chelating agent disulfiram
|
Shiah, SG; Kao, YR; Wu, FYH; Wu, CW |
| 中國醫藥大學 |
2003-11 |
Structural basis of a flavivirus recognized by its neutralizing antibody: solution structure of the domain III of the Japanese encephalitis virus envelope protein.
|
(Wu KP); (Wu CW); (Tsao YP); (Kuo TW); (Lou YC); 林振文(Cheng-Wen Lin); (Wu SC); (Cheng JW) |
| 國家衛生研究院 |
2003-07-15 |
Antitumor and antimetastatic activity of IL-23
|
Lo, CH; Lee, SC; Wu, PY; Pan, WY; Su, J; Cheng, CW; Roffler, SR; Chiang, BL; Lee, CN; Wu, CW; Tao, MH |
| 國家衛生研究院 |
2003-07 |
Tumor-associated antigen L6 and the invasion of human lung cancer cells
|
Kao, YR; Shih, JY; Wen, WC; Ko, YP; Chen, BM; Chan, YL; Chu, YW; Yang, PC; Wu, CW; Roffler, SR |
| 國立臺灣大學 |
2003-07 |
Antitumor and antimetastasis activity of IL-23
|
Lo, CH; Lee, SC; Wu, PY; Su, J; Cheng, CW; Roffler, SR; Chiang, BL; Lee, CN; Wu, CW; Tao, MH. |
| 國家衛生研究院 |
2003-06 |
Functional analysis of EBV in nasopharyngeal carcinoma cells
|
Wu, HC; Lin, YJ; Lee, JJ; Liu, YJ; Liang, ST; Peng, Y; Chiu, YW; Wu, CW; Lin, CT |
| 國家衛生研究院 |
2003-06 |
The retrospect and prospect of in vitro tumor invasion assay techniques
|
Chang, WSW;Lin, SC;Lin, KC;Kao, YR;Chou, RH;Chi, CY;Wu, CW |
| 國家衛生研究院 |
2003-05 |
Cadherin and catenin expression in mucoepidermoid carcinoma: correlation with histopathologic grade, clinical stage, and patient outcome
|
Shieh, YS; Chang, LC; Chiu, KC; Wu, CW; Lee, HS |
| 國家衛生研究院 |
2003-02-21 |
Up-regulation of vascular endothelial growth factor C in breast cancer cells by heregulin-beta 1
|
Tsai, PW; Shiah, SG; Lin, MT; Wu, CW; Kuo, ML |
顯示項目 136-145 / 215 (共22頁)
<< < 9 10 11 12 13 14 15 16 17 18 > >>
每頁顯示[10|25|50]項目
|
